BLUEPRINT MEDICINES CORP (BPMC) Forecast, Price Target & Analyst Ratings

NASDAQ:BPMC • US09627Y1091

Current stock price

129.46 USD
+0.18 (+0.14%)
At close:
129.5 USD
+0.04 (+0.03%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BLUEPRINT MEDICINES CORP (BPMC).

Forecast Snapshot

Consensus Price Target

Price Target
$132.96
+ 2.71% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 30, 2025
Period
Q2 / 2025
EPS Estimate
-$0.54
Revenue Estimate
174.55M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
68.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$132.96
Upside
+ 2.71%
From current price of $129.46 to mean target of $132.96, Based on 25 analyst forecasts
Low
$130.29
Median
$131.58
High
$141.75

Price Target Revisions

1 Month
0.02%
3 Months
3.46%

Price Target Summary

25 Wall Street analysts provided a forecast for the next 12 months for BPMC. The average price target is 132.96 USD. This implies a price increase of 2.71% is expected in the next year compared to the current price of 129.46.
The average price target has been revised upward by 3.46% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

BPMC Current Analyst RatingBPMC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

BPMC Historical Analyst RatingsBPMC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
68.00%
BPMC was analyzed by 25 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about BPMC.
In the last month the buy percentage fell by 12 points. So the trust of analysts is decreasing.
BPMC was analyzed by 25 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-06-17Wells FargoDowngrade Overweight -> Equal-Weight
2025-06-05UBSMaintains Neutral -> Neutral
2025-06-05Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-06-04CitigroupUpgrade Sell -> Neutral
2025-06-03Wolfe ResearchDowngrade Outperform -> Peer Perform
2025-06-03JMP SecuritiesDowngrade Market Outperform -> Market Perform
2025-06-03Stephens & Co.Downgrade Overweight -> Equal-Weight
2025-06-02ScotiaBankDowngrade Sector Outperform -> Sector Perform
2025-06-02NeedhamDowngrade Buy -> Hold
2025-06-02WedbushDowngrade Outperform -> Neutral
2025-06-02JP MorganDowngrade Overweight -> Neutral
2025-05-02HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-28NeedhamMaintains Buy -> Buy
2025-04-16WedbushReiterate Outperform -> Outperform
2025-04-08NeedhamReiterate Buy -> Buy
2025-03-17JefferiesInitiate Buy
2025-03-07ScotiaBankInitiate Sector Outperform
2025-03-03Citizens Capital MarketsReiterate Market Outperform -> Market Outperform
2025-02-14JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-02-14NeedhamReiterate Buy -> Buy
2025-02-14HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-13NeedhamReiterate Buy -> Buy
2025-02-04JP MorganMaintains Overweight -> Overweight
2025-01-27Piper SandlerMaintains Neutral -> Neutral
2025-01-15JMP SecuritiesReiterate Market Outperform -> Market Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 30, 2025
Period
Q2 / 2025
EPS Estimate
-$0.54
Revenue Estimate
174.55M
Revenue Q2Q
26.34%
EPS Q2Q
32.99%
Number of Analysts
22

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-2.18%
EPS (1 Month)
0.00%
EPS (3 Months)
-36.40%

Next Earnings Summary

BPMC is expected to report earnings on 7/30/2025. The consensus EPS estimate for the next earnings is -0.54 USD and the consensus revenue estimate is 174.55M USD.
The next earnings revenue estimate has been revised downward by 2.18% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
BPMC revenue by date.BPMC revenue by date.
204M
13.27%		249.38M
22.25%		508.824M
104.04%		735.04M
44.46%		975.99M
32.78%		1.211B
24.08%		1.46B
20.56%		1.665B
14.04%		1.872B
12.43%		2.098B
12.07%		2.285B
8.91%
EBITDA
YoY % growth
BPMC ebitda by date.BPMC ebitda by date.
-525.8M
17.26%		-474.612M
9.74%		-195.753M
58.76%		-83.11M
57.54%		89.325M
207.48%		279.58M
212.99%		399.84M
43.01%		556.22M
39.11%		650.34M
16.92%		844.14M
29.80%		1.178B
39.55%
EBIT
YoY % growth
BPMC ebit by date.BPMC ebit by date.
-537.5M
16.28%		-486.277M
9.53%		-212.044M
56.39%		-79.605M
62.46%		98.89M
224.23%		303.76M
207.17%		485.33M
59.77%		661.21M
36.24%		761.24M
15.13%		970.77M
27.52%		1.128B
16.20%
Operating Margin
BPMC operating margin by date.BPMC operating margin by date.
-263.48%-194.99%-41.67%-10.83%10.13%25.08%33.24%39.71%40.66%46.27%49.37%
EPS
YoY % growth
BPMC eps by date.BPMC eps by date.
-9.35
14.38%		-8.36
10.59%		-3.80
54.55%		-0.91
76.13%		0.99
208.82%		4.23
328.73%		4.77
12.82%		5.78
21.15%		6.48
11.99%		22.60
248.98%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.54
32.99%		-0.26
70.44%		-0.18
77.65%		-0.01
99.31%		0.27
151.23%		0.39
248.58%		0.31
276.75%
Revenue
Q2Q % growth		174.55M
26.34%		194.92M
52.06%		212.06M
44.88%		212.54M
42.25%		238.99M
36.92%		254.85M
30.75%		269.84M
27.25%
EBITDA
Q2Q % growth		-27.499M
20.56%		-17.213M
53.08%		-11.929M
52.12%		29.58M
180.76%		35.7M
229.82%		41.82M
342.96%		46.92M
493.33%
EBIT
Q2Q % growth		-26.255M
39.01%		-11.021M
77.50%		-537.479K
98.70%		1.656M
104.03%		25.149M
195.79%		30.03M
372.47%		32.16M
6,083.49%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BPMC Yearly Revenue VS EstimatesBPMC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
BPMC Yearly EPS VS EstimatesBPMC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 10 -10 20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
46.02%
EPS Next 5 Year
28.63%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
32.66%
Revenue Next 5 Year
26.27%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
49.05%
EBIT Next 5 Year
35.74%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BLUEPRINT MEDICINES CORP / BPMC Forecast FAQ

What do analysts expect the price target to be for BLUEPRINT MEDICINES CORP (BPMC)?

25 analysts have analysed BPMC and the average price target is 132.96 USD. This implies a price increase of 2.71% is expected in the next year compared to the current price of 129.46.

What is the next earnings date for BPMC stock?

BLUEPRINT MEDICINES CORP (BPMC) will report earnings on 2025-07-30, before the market open.

Can you provide the consensus estimates for BLUEPRINT MEDICINES CORP next earnings?

The consensus EPS estimate for the next earnings of BLUEPRINT MEDICINES CORP (BPMC) is -0.54 USD and the consensus revenue estimate is 174.55M USD.

Can you provide the consensus rating for BLUEPRINT MEDICINES CORP stock?

The consensus rating for BLUEPRINT MEDICINES CORP (BPMC) is 68 / 100 . This indicates that analysts generally have a neutral outlook on the stock.